NanoString Technologies Aktie [WKN DE: A1W1X2 / ISIN: US63009R1095]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu NanoString Technologies Inc

24.02.22		NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference (Businesswire)
24.02.22		NanoString to Showcase CosMx Spatial Molecular Imager at 4th Annual Spatial Genomics Summit, Feb. 28 (Businesswire)
09.02.22		NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference (Businesswire)
07.02.22		NanoString to Release Fourth Quarter and Fiscal Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022 (Businesswire)
10.01.22		NanoString Reports Inducement Grant Under Nasdaq Listing Rules (Businesswire)
09.01.22		NanoString Announces Commercial Leadership Transition (Businesswire)
09.01.22		NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021 (Businesswire)
21.12.21		NanoString to Webcast Presentation from the 40th Annual JP Morgan Healthcare Conference (Businesswire)
08.07.21		NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021 (Businesswire)
27.05.21		NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference (Businesswire)
20.05.21		NanoString to Webcast Presentation from the UBS Global Healthcare Conference (Businesswire)
10.05.21		NanoString Technologies Releases Operating Results for First Quarter of 2021 (Businesswire)
08.04.21		NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference (Businesswire)
31.03.21		NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications (Businesswire)
01.03.21		NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook (Businesswire)
24.02.21		NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference (Businesswire)
22.02.21		NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021 (Businesswire)
17.02.21		NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference (Businesswire)
11.02.21		NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021 (Businesswire)
09.02.21		Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas (Businesswire)
10.01.21		NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020 (Businesswire)
06.01.21		Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020 (Businesswire)
04.01.21		NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference (Businesswire)
09.12.20		NanoString’s GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications (Businesswire)
01.12.20		NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology (Businesswire)
18.11.20		NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020 (Businesswire)
17.11.20		NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer (Businesswire)
12.11.20		NanoString to Present at the Stifel 2020 Virtual Healthcare Conference (Businesswire)
11.11.20		NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC) (Businesswire)
09.11.20		NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing (Businesswire)
06.11.20		NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference (Businesswire)
13.10.20		NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares (Businesswire)
08.10.20		NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock (Businesswire)
06.10.20		NanoString Technologies Announces Commencement of Public Offering of Common Stock (Businesswire)
06.10.20		NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020 (Businesswire)
05.10.20		NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020 (Businesswire)
14.09.20		NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites (Businesswire)
09.09.20		NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference (Businesswire)
10.08.20		NanoString Technologies Releases Operating Results for Second Quarter of 2020 (Businesswire)
06.08.20		NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler (Businesswire)
03.08.20		NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers (Businesswire)
08.07.20		NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020 (Businesswire)
16.06.20		NanoString Announces New Products to Advance COVID-19 Disease Research (Businesswire)
20.05.20		NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data (Businesswire)
14.05.20		NanoString to Present at the UBS Global Healthcare Conference (Businesswire)
11.05.20		NanoString to Present at the Bank of America Health Care Conference (Businesswire)
07.05.20		NanoString Technologies Releases Operating Results for First Quarter of 2020 (Businesswire)
15.04.20		Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus (Businesswire)
06.04.20		NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020 (Businesswire)
05.03.20		NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

NVIDIA vor Q3-Ergebnissen: Hohe Erwartungen und höhere Kursziele für den KI-Giganten

Solana noch in diesem Jahr bei 300 US-Dollar?

UN-Klimagipfel in Baku: Baerbock warnt vor 'Killerstürmen'

Angespannte Stimmung in Frankfurt: LUS-DAX gibt am Nachmittag nach

BlackRocks Bitcoin-ETF überholt Gold-ETF

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	22.11.2024 21:52
Kaufwert:	EUR
	Hinzufügen Speichern